Cancer Journey


VIDEOS

GRACE is pleased to present updates in blood cancer treatments for our Spanish Blood Cancer Library with Dr. Marco Ruiz. Dr. Ruiz shares information...

GRACE sat down with Dr. Marco Ruiz to discuss information regarding the chimeric T cell receptors treatment against tumoral antigens (CAR-T) and how...

For this series, GRACE sat down with Marco Ruiz, MD, an oncologist at Memorial Cancer Institute specializing in hematologic or blood cancers...

For this video on the risks and benefits of Ibrutinib Idelalisib, GRACE sat down with Marco Ruiz, MD, an oncologist at Memorial Cancer Institute...

Two of GRACE's earliest followers, Laya Dogmetchi and Jim Celebucki, talk about how the Global Resource for Advancing Cancer Education helps cancer...

ARTICLES

ONLINE COMMUNITY

RECENT POSTS

Blood Cancers Video Library: CLL and Non Hodgkin Lymphoma: Should all Hodgkin’s Lymphoma patients be treated the same?

Video

GRACE joined a number of top faculty in the area of hematology in Whistler BC, for the 3rd Annual Summit on Hematologic Malignancies. John Kuruvilla, MD, Associate Professor, Princess Margaret Hospital, University Health Network in Toronto, Canada, spoke with GRACE about Chronic Lymphocytic Leukemia (CLL) and Non Hodgkin Lymphoma, and explained that all all Hodgkin’s Lymphoma patients are not treated the same. Much is based on the risk profile in terms of the amount of disease, which will often dictate the treatment approach.


TRANSCRIPT 

 

Blood Cancers Video Library: Are Vaccines Dead in Lymphoma and CLL?

Video

GRACE joined a number of top faculty in the area of hematology in Whistler BC, for the 3rd Annual Summit on Hematologic Malignancies.  Joshua Brody, MD, Oncologist and Director, Assistant Professor of Medicine, Hematology & Medical Oncology at Mount Sinai Hospital spoke with GRACE about the question of whether vaccines are dead in Lymphoma and CLL. 


Are Vaccines Dead in Lymphoma and CLL?

Blood Cancers Video Library: FCR vs BR – Is One Better?

Video

GRACE joined a number of top faculty in the area of hematology in Whistler BC, for the 3rd Annual Summit on Hematologic Malignancies. Jennifer Brown, MD, PhD, Director of the CLL Center at the Dana-Farber Cancer Institute spoke with GRACE and provided a provoking and educational discussion on FCR vs. BR – is one better than the other?


TRANSCRIPT

 

FCR v BR? Is one better?

Jennifer Brown, MD, PhD, Director of the CLL Center at the Dana-Farber Cancer Institute

Blood Cancer Video Library - What Is The Significance Of IGHV Mutations And How Are They Assessed?

Video

We recently joined a number of top faculty in the area of hematology in Whistler BC, for the 3rd Annual Summit on Hematologic Malignancies.

Jennifer Brown, MD, PhD, Director of the CLL Center at the Dana-Farber Cancer Institute spoke with GRACE and provided provoking and educational discussions on the significance of IGHV mutations and how they are assessed. We invite you to watch this first video from our Blood Cancers Library Video collection.

Stay tuned for more educational videos soon to come!

Subscribe to Blood Cancer